Answers - Legal

The FDA needs to reduce its rules and regulations to help the mar

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ket place participate in capitalism and help the consumer and the

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

American people so they can enjoy lower prices, better quality p

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

roducts and safer foods.

The FDA needs to reduce its rules and r

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

egulations in order to prevent trial lawyers from suing companies

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

for millions of dollars, which does nothing more than make the t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

rial lawyers richer and raise the prices for consumers. The FDA i

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

s a part of the blob of bureaucracy and preventing the American p

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

eople from enjoying quality of life and better standard of living

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

.

We must reduce the rules and regulations of the FDA in order t

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

o get drugs to market earlier to save more lives and to open up t

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

he floodgates of competition for companies and research firms who

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

are on the cutting edge of biotech. The FDA is in the way and th

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

eir rules and regulations need to be reduced and overhauled in or

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

der to streamline the efficiencies of business that is in the foo

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

d and drug industry.

Without a reduction of the rules and regula

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

tions it will further stifle business and end up hurting the Amer

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ican people. The FDA is too large of a bureaucracy to be of any

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

use to the American people. Let's reduce the rules and regulatio

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ns and overhaul the system at the FDA. Please consider this 2006

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/131301/answers-FDA-Needs-Rules-and-Regulations-Overhaul.html">FDA Needs Rules and Regulations Overhaul</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/131301/answers-FDA-Needs-Rules-and-Regulations-Overhaul.html]FDA Needs Rules and Regulations Overhaul[/url]

This second in a series of three articles examines staff turnover in the light of productivity, liability, and financial returns to the medical practice.

Like any adventure,when you begin networking you may have some fear and trepidation about facing the unexpected, but you should also feel some of the thrill of the challenge and excitement in finding new people with whom you can really connect. By making time in your schedule to network, you can use early opportunities to watch others networking and to get into the habit of talking to the people you meet. Don’t forget, networking successfully means that we sometimes have to stretch ourselves to the edges of our comfort zones – hard at first but much easier with practice.

It is becoming increasingly popular to use a mortgage in lieu of a low-interest savings account. Is this a good idea?

Tags

Links

Answers - FDA Needs Rules and Regulations Overhaul

Related Articles: